Published in Cardiovascular Device Liability Week, April 18th, 2004
The additional award brings to $2.9 million the total services contracted to eRT for this single clinical trial.
The agreement covers an extension to a significant phase III study for which eRT was already providing comprehensive support, including the provision, training and ongoing assistance required for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.